Dr. Yu

Amakuru

 Dr. Yu 

2025-02-11

Muganga Yu yoofa numurwi wa Amerika yasohoye hamwe ingingo yo gusuzuma ingingo ya autontibolies nyinshi zijyanye na antigos nka kanseri ya pagreatic mu kinyamakuru no kwitoza.

Intego y'ubu bushakashatsi kwari ugusuzuma ubusobanuro bwa kavukire ya autontibolies kurwanya Gna11, Mnas, MDM2, P16, CANI1, Calnuc, umugozi muri kanseri ya pancreatic (PC). Ingero 33 ya Serum yaturutse ku barwayi 45 na 45 yo kugenzura ibisanzwe (NC) byashyizwemo, kandi ubwoko 9 bwa ​​autontibodiboli bwagaragaye ukoresheje Enzyme-Lyzymes Assay (Elisa). Subiza ukoresheje ibipimo byinshi muburyo bwumuntu cyangwa uhujwe. Usibye Anti Gnas na Anti Calnuc, urwego rwabandi bagare bose bari hejuru cyane kurenza abari mumatsinda asanzwe yo kugenzura. Ugereranije n'itsinda risanzwe ryo kugenzura (4.9%), inshuro zingahe zagantu, PNLN, byiyongereye, na Sui1, 6,6.7%, na 27.3%. Ubushobozi bwa autontibodibodibodibodibodigos kugirango itandukane agace munsi ya roc umurongo (auc) kuva kuri 0.666 kugeza kuri 0.884, hamwe na 0.884) na 0.857) Kugaragaza imikorere ikomeye yo gusuzuma. Ihuriro rya anti-msln na anti-p16 rishobora kunoza kumva kwisuzumisha.

Byongeye kandi, MSLN na Sui1 Auto1Antibors yagabanutse mubarwayi ba PC nyuma ya chimitherapie. Autontibodiboli enye kuri Msln, P16, Sui1 na PNT yerekanaga ibipimo bishobora gusuzuma ya kanseri ya panreatic kuri kanseri ya Pancreatic, muri yo anti msln na anti p16 byari byiza. Guhuza aba bombi bautontibods byerekana ubushobozi bwubukungu kandi bufatika. Akamaro ko kugabanuka katoantibodiboli kuri msln na sui1 mubarwayi ba PC nyuma ya chimitherapie ikeneye ubundi bushakashatsi.

Ubushakashatsi kuri wigitarubine bijyanye nautoibodidigo bitanga icyerekezo cyingenzi cyo gusuzuma hakiri kare, kwisuzumisha, no kuvura ibibyimba. Amasomo Yu Baofa yakoresheje ibibyimba byo mu kibyimba mubyibuvuzi mu myaka irenga 20 ishize.

Urugo
Imanza zisanzwe
Ibyacu
Twandikire

Nyamuneka tudusige ubutumwa